These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ; J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291 [TBL] [Abstract][Full Text] [Related]
23. Carcinoma in situ of the bladder. Utz DC; Farrow GM; Rife CC; Segura JW; Zincke H Cancer; 1980 Apr; 45(7 Suppl):1842-8. PubMed ID: 7370935 [No Abstract] [Full Text] [Related]
24. Biopsy of the red patch at cystoscopy: is it worthwhile? Swinn MJ; Walker MM; Harbin LJ; Adshead JM; Witherow RO; Vale JA; Patel A Eur Urol; 2004 Apr; 45(4):471-4; discussion 474. PubMed ID: 15041111 [TBL] [Abstract][Full Text] [Related]
31. A case of spontaneous rupture perforation of sarcomatoid carcinoma in the urinary bladder. Sallami S; Chelly I; Kacem C; Ben Slima M Tunis Med; 2013; 91(8-9):553-4. PubMed ID: 24227517 [No Abstract] [Full Text] [Related]
32. Survival of patients with carcinoma in situ of the urinary bladder. Cheng L; Cheville JC; Neumann RM; Leibovich BC; Egan KS; Spotts BE; Bostwick DG Cancer; 1999 Jun; 85(11):2469-74. PubMed ID: 10357420 [TBL] [Abstract][Full Text] [Related]
33. Correlation of cytology with histopathology and cystoscopy in urinary bladder tumours. Javali D; Singh SM; Gupta NP; Wadhwa SN Indian J Cancer; 1981 Dec; 18(4):241-4. PubMed ID: 7341421 [No Abstract] [Full Text] [Related]
34. [Bladder carcinoma treated only symptomatically: indications and results]. Pum H; Reichelt H; Schimatzek A Helv Chir Acta; 1973 Sep; 40(4):477-80. PubMed ID: 4127726 [No Abstract] [Full Text] [Related]
35. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419 [TBL] [Abstract][Full Text] [Related]
36. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma. Babjuk M; Soukup V; Pesl M; Kostírová M; Drncová E; Smolová H; Szakacsová M; Getzenberg R; Pavlík I; Dvorácek J Urology; 2008 Apr; 71(4):718-22. PubMed ID: 18387400 [TBL] [Abstract][Full Text] [Related]
37. Pathological variants of invasive bladder cancer according to their suggested clinical significance. Lopez-Beltran A; Requena MJ; Cheng L; Montironi R BJU Int; 2008 Feb; 101(3):275-81. PubMed ID: 17986288 [TBL] [Abstract][Full Text] [Related]
38. [Carcinoma in situ in the urinary bladder]. Katusin D; Poka Z; Mlinac-Lucijanić M; Kriz M; Klarić-Vucinić S; Ilijanić J Lijec Vjesn; 2000; 122(7-8):177-9. PubMed ID: 11048460 [TBL] [Abstract][Full Text] [Related]
39. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Hilmy M; Bartlett JM; Underwood MA; McMillan DC Br J Cancer; 2005 Feb; 92(4):625-7. PubMed ID: 15726119 [TBL] [Abstract][Full Text] [Related]
40. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]